Russo I, Cazzolla S, Pampaloni F, Alaibac M. Omalizumab for the treatment of chronic spontaneous urticaria: association between body mass index and outcome. Dermatol Pract Concept [Internet]. 2022 Oct. 31 [cited 2026 May 8];12(4):e2022148. Available from: https://www.dpcj.org/index.php/dpc/article/view/2053